Gene Silencing of TGFβRII Can Inhibit Glioblastoma Cell Growth

OBJECTIVE: Glioblastoma (GBM) is the most malignant and aggressive type of glioma, associated with a high rate of mortality. The transforming growth factor-β receptor II (TGFβ RII) is involved in glioma initiation and progression. On the other hand, TGFβ RII silencing is critical to the inhibition o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Asian Pac J Cancer Prev
Hlavní autoři: Aval, Farzane Ordoni, Amiri, Shaghayegh Askarian, Azadmehr, Abbas, Oladnabi, Morteza, Saadat, Payam, Ebrahimi, Hadi, Baradaran, Behzad, Mansoori, Behzad, Pourabdolhossein, Fereshteh, Torabian, Pedram, Hajiahmadi, Mahmoud
Médium: Artigo
Jazyk:Inglês
Vydáno: West Asia Organization for Cancer Prevention 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6249455/
https://ncbi.nlm.nih.gov/pubmed/30256570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.9.2681
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky